Biofrontera Inc. (BFRI) vs Lantern Pharma Inc. (LTRN)

A side-by-side comparison of Biofrontera Inc. and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Biofrontera Inc. logo
BFRI
Biofrontera Inc.
$12M
$0.91HealthcareDelayed quote: Oct 6, 2026, 11:47 AM EDT
Lantern Pharma Inc. logo
LTRN
Lantern Pharma Inc.
$13M
$0.98HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT

Total return — BFRI vs LTRN

growth of $100 · dividends reinvested · last 5y
BFRI -99.0% (-60.1%/yr)LTRN -90.8% (-37.9%/yr)LTRN compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$1$9
BFRI LTRN

BFRI vs LTRN: by the numbers

  • •LTRN is the larger company ($13M vs $12M market cap).
  • •Both run net losses; LTRN's is the smaller (0.00% vs -13.78% net margin).

Metrics side by side

Valuation

MetricBFRILTRN
P/S ratio0.25N/A
P/B ratio1.96N/A

Profitability

MetricBFRILTRN
Gross margin84.45%0.00%
Operating margin-21.94%0.00%
Net margin-13.78%0.00%
ROE-106.87%N/A
ROIC-32.27%-358.04%

Growth (annualized)

MetricBFRILTRN
Revenue CAGR (5Y)15.55%N/A
Total return CAGR (5Y)N/A-37.05%

Go deeper

Full BFRI analysisFull LTRN analysisInteractive comparison tool

Dig into the metrics

Biofrontera ROELantern Pharma ROEBiofrontera operating marginLantern Pharma operating marginBiofrontera revenue growthLantern Pharma revenue growthBiofrontera free cash flowLantern Pharma free cash flow

Biofrontera & Lantern Pharma appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.